Stock Market & Financial Investment News

News Breaks January 30, 2013 07:16 EDT IDIX Idenix downgraded to Neutral from Outperform at Wedbush Wedbush said Idenix's (IDIX) collaboration with Johnson & Johnson (JNJ) lacks clarity long-term given the competitive space and Johnson & Johnson's collaborations with BMS and Vertex. Price target lowered to $6 from $7. News For IDIX From The Last 14 Days Check below for free stories on IDIX the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 21, 2013 07:34 EDT IDIX UBS to host a conference Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.